Guidelines for Cardiac Clearance for Non-Emergent Surgery
The cardiac clearance process for non-emergent surgery should follow a stepwise approach based on clinical risk factors, functional capacity, and surgical risk to minimize perioperative cardiac complications.
Step 1: Determine Urgency of Surgery
- Assess if surgery is emergent, urgent, or elective 1
- For emergent surgery, proceed with appropriate monitoring and management strategies based on clinical assessment 1
Step 2: Screen for Active Cardiac Conditions
- Identify any active cardiac conditions that require evaluation and treatment before non-cardiac surgery 1:
- Unstable coronary syndromes (unstable angina, recent MI)
- Decompensated heart failure
- Significant arrhythmias
- Severe valvular disease 1
Step 3: Assess Surgical Risk
- Determine the cardiac risk associated with the planned procedure 1:
- Low-risk procedures (<1% risk): endoscopy, superficial procedures, cataract surgery, breast surgery
- Intermediate-risk procedures (1-5% risk): intraperitoneal/intrathoracic procedures, carotid endarterectomy, head and neck surgery
- High-risk procedures (>5% risk): major vascular procedures, prolonged surgeries with large fluid shifts 1
Step 4: Evaluate Functional Capacity
- Assess the patient's functional capacity in metabolic equivalent tasks (METs) 1:
Step 5: Determine Clinical Risk Factors
- Identify clinical risk factors from the Revised Cardiac Risk Index 1:
- History of ischemic heart disease
- History of heart failure
- History of cerebrovascular disease
- Diabetes mellitus requiring insulin
- Renal insufficiency (creatinine >2 mg/dL) 1
Step 6: Decision for Further Testing
- For patients with poor functional capacity (<4 METs) 1:
Step 7: Preoperative Testing Recommendations
- Resting 12-lead ECG is reasonable for patients with known coronary heart disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, or structural heart disease 1
- Echocardiography is recommended for patients with:
- Troponin measurement is recommended only for patients with signs or symptoms of myocardial ischemia or MI 1
Special Considerations
Valvular Heart Disease
- For patients with severe valvular heart disease, clinical and echocardiographic evaluation is recommended before non-cardiac surgery 1
- For asymptomatic patients with severe aortic stenosis, elevated-risk elective non-cardiac surgery with appropriate monitoring is reasonable 1
- For symptomatic patients with severe valvular disease, valve intervention before elective non-cardiac surgery is effective in reducing perioperative risk 1
Perioperative Management
- Routine use of pulmonary artery catheterization is not recommended 1
- Prophylactic intravenous nitroglycerin is not effective in reducing myocardial ischemia 1
- Routine use of intraoperative transesophageal echocardiogram is not recommended 1
- Maintenance of normothermia may be reasonable to reduce perioperative cardiac events 1
Common Pitfalls to Avoid
- Routine stress testing in low-risk patients is not recommended and may lead to unnecessary delays in surgery 2
- Routine coronary revascularization before non-cardiac surgery does not reduce perioperative risk and should not be performed without specific indications independent of planned surgery 2, 3
- High-dose β-blockers administered shortly before surgery are associated with increased risk of stroke and mortality 2
- Routine postoperative screening with troponin levels in unselected patients without signs or symptoms of myocardial ischemia is not recommended 1